Article thumbnail

Accurate non-invasive image-based cytotoxicity assays for cultured cells

By Patricia Marqués-Gallego, Hans den Dulk, Claude Backendorf, Jaap Brouwer, Jan Reedijk and Julian F Burke
Topics: Methodology Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2906423
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1986). Altman DG: Statistical-Methods For Assessing Agreement Between 2 Methods Of Clinical Measurement. Lancet
  2. (1991). Cell-Mediated Cytotoxicity Against U-937 Cells By Human Monocytes And Macrophages In A Modified Colorimetric Mtt Assay - A Methodological Study.
  3. (2009). Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
  4. (2002). Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci
  5. (2009). Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Biochem Pharmacol
  6. (1996). Darling JL: Assay of anticancer drugs in tissue culture: Comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Anti-Cancer Drugs
  7. (2002). DI: In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
  8. (1987). Neubauer RH: Semiautomated Colorimetric Assay For Invitro Screening Of Anticancer Compounds. Cancer Treatment Reports
  9. (2003). New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
  10. (1999). Peters GJ: Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
  11. (1992). Prediction Of Response To Drug-Therapy Of Cancer - A Review Of Invitro Assays. Drugs
  12. (1986). Rapid Colorimetric Assay For Cell-Growth And Survival - Modifications To The Tetrazolium Dye Procedure Giving Improved Sensitivity And Reliability. J Immunol Methods
  13. (1983). Rapid Colorimetric Assay For Cellular Growth And Survival - Application To Proliferation And Cyto-Toxicity Assays. J Immunol Methods
  14. (1989). SB: Effects Of The Ph-Dependence Of 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyl-Tetrazolium Bromide-Formazan Absorption On Chemosensitivity Determined By A Novel TetrazoliumBased Assay. Cancer Res
  15. (1989). Scudiero N: Evaluation of colorimetric protein and biomass stains for assaying in vitro drug effects upon human tumor cell lines. Proc Am Assoc Cancer
  16. (2004). SS: Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F. Leuk Res
  17. (1989). Status of the NCI preclinical antitumor drug discovery screen. Princ Pract Oncol
  18. (1991). Use Of An Aqueous Soluble Tetrazolium Formazan Assay For Cell-Growth Assays In Culture. Cancer Communications